Keyphrases
Anthracyclines
100%
Cancer Patients
100%
Dexrazoxane
100%
Cardioprotection
100%
Cardioprotective Agents
55%
Adverse Effects
44%
In Cancer
22%
Randomized Controlled Trial
22%
Cardiotoxicity
22%
Response Rate
22%
N-acetylcysteine
22%
Heart Injury
22%
Malignancy
11%
Pediatric Oncology
11%
Meta-analysis
11%
International Society
11%
Selection Criteria
11%
Additional Therapy
11%
Patients with Cancer
11%
Cochrane Library
11%
Embase
11%
Dose Effect
11%
Vitamin E
11%
No Significant Difference
11%
MEDLINE
11%
Data Extraction
11%
Vitamin C
11%
Placebo
11%
Significant Benefit
11%
Secondary Malignancy
11%
Risk of Bias Assessment
11%
Ongoing Trials
11%
Conference Proceedings
11%
Risk Ratio
11%
Review Authors
11%
Cochrane Central Register of Controlled Trials
11%
Methodological Limitations
11%
American Society of Clinical Oncology
11%
Search Methods
11%
Cardiac Damage
11%
Coenzyme Q10
11%
Amifostine
11%
Heart Failure Risk
11%
Carvedilol
11%
Advanced Breast Cancer
11%
Phenethylamines
11%
L-carnitine
11%
Selection Risk
11%
Medicine and Dentistry
Malignant Neoplasm
100%
Anthracycline
100%
Dexrazoxane
100%
Adverse Event
44%
Heart Injury
33%
Cancer
22%
Randomized Controlled Trial
22%
Cardiotoxicity
22%
Acetylcysteine
22%
Childhood Cancer
11%
Breast Cancer
11%
Meta-Analysis
11%
Alpha Tocopherol
11%
Clinician
11%
Ascorbic Acid
11%
Placebo
11%
Congestive Heart Failure
11%
Clinical Oncology
11%
Coenzyme Q10
11%
Amifostine
11%
Carnitine
11%
Phenethylamine Derivative
11%
Carvedilol
11%
Nursing and Health Professions
Malignant Neoplasm
100%
Anthracycline
100%
Razoxane
100%
Adverse Event
44%
Heart Injury
33%
Cochrane Library
22%
Acetylcysteine
22%
Cardiotoxicity
22%
Childhood Cancer
11%
Meta Analysis
11%
Data Extraction
11%
Chemotherapy
11%
Congestive Heart Failure
11%
Ascorbic Acid
11%
Alpha Tocopherol
11%
Breast Cancer
11%
Ubidecarenone
11%
Placebo
11%
Carnitine
11%
Phenethylamine Derivative
11%
Carvedilol
11%
Amifostine
11%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Anthracycline
100%
Razoxane
100%
Adverse Event
44%
Heart Injury
33%
Randomized Controlled Trial
22%
Cardiotoxicity
22%
Acetylcysteine
22%
Childhood Cancer
11%
Alpha Tocopherol
11%
Ascorbic Acid
11%
Placebo
11%
Breast Cancer
11%
Congestive Heart Failure
11%
Ubidecarenone
11%
Amifostine
11%
Carvedilol
11%
Phenethylamine Derivative
11%
Carnitine
11%